Logo 2021 MediumAsiaWorld-Expo
Hong Kong
10-13/03/2021
10-13/03/2020
Asset 2brandhk en scaled 2
 
 
 
 
X

BIOHK2021 Update 香港国际生物科技展資訊更新

BIOHK is an international convention organized by Hong Kong Biotechnology Organization to introduce novel state-of-the-art biotech innovations from around the globe and provide an extensive platform to allow pioneers of the biotech industry to convene, with the purpose of promoting Hong Kong as an international innovation hub for biotech.

However, due to the COVID-19 epidemic, BIOHK2021 had to be postponed several times and now has been decided to be postponed to 10-13 March 2021. In view of the continuing uncertainties amidst the COVID-19 epidemic, the safety of participants is definitely our prioritized concern. For any subsequent changes, we will promptly notify all stakeholders and exhibitors for getting better prepared and arranged.

It’s true that COVID-19 brings us plenty of negative impacts, on another hand, it arouses awareness in biotech and speeds up the biotech development. BIOHK2021 must be the first International Biotech Convention when COVID-19 is over. So please reserve your time to join this significant biotech event in Hong Kong.

BIOHK2021 team hereby expresses our gratitude for all those supporting to BIOHK2021. We will continue to try our best in organizing BIOHK2021, which brings biotech industry an international biotech event, with the purpose of promoting the biotech development.

Please visit this website or email to info@biohk.org.hk for any enquiries.

香港国际生物科技展是由香港生物科技协会所举办的国际会议,引入全球最创新的生物技术,及提供一个让生物科技行业聚集一堂的平台,旨在促进香港成为国际生物科技创新中心。

可是,受到新型冠状病毒疫情影响,香港国际生物科技展已推迟数次,而香港国际生物科技展现已决定延至2021年3月10日至13日举办。由于疫情存在变量,参加者安全必然是我们首要的考虑。如果科技展有任何变动,我们亦会适时通知各持份者及参展商,确保各方有充足时间作准备及安排。

确实,COVID-19给我们带来了很多负面影响,但另一方面,它引起了人们对生物科技的关注及加快生物科技的发展。当新冠肺炎结束时,香港国际生物科技展必会是第一个举办的国际生物科技大会,所以请预留时间参加这个于香港举办的生物科技盛会。

香港国际生物科技展筹委会在此感谢各方的支持,我们会尽最大努力办好香港国际生物科技展,为生物科技界带来一个国际性的生物科技活动,以促进生物科技发展。

如有查询,请浏览本网站或电邮至 info@biohk.org.hk

Surname in Alphabetical Order

President and CEO, National Foundation for Cancer Research

Senior Executive Director, Hong Kong Association of the Pharmaceuticals Industry

Chairman, Pan Asia Venture Development Platform (PAVD)

VP & Head of Corporate Development, WuXi Biologics

Investment Director, Affix Capital

Former Superintendent, Hong Kong Police Force

Business Consultant, Wise Ally Holdings Ltd

CEO, Pangenia Inc and DiagCor Life Science Ltd.

Professor, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology

Founder, Ryoden Medical Holdings Limited and Co-founder, Incando Therapeutics

Chairman of the Board, Great Treasure International / Galaxy Treasure Group

Founder, President and CEO, ASC Therapeutics, Inc.

CEO, Queens (Shenzhen) Biotechnology Co., Ltd.

Managing Partner & Co-founder, Serica Capital

Hong Kong TMT Leader, Deloitte

Senior Partner, Head of Greater China, McKinsey & Company

Associate Professor, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong

Vice President, Portfolio Management and Research

Lo Ka Chung Charitable Foundation Professor in Pharmaceutical Sciences Professor and DoULS

President, LiLaw Inc.

Partner, Summer Capital

CEO, Lee's Pharmaceutical Holdings Limited

Chair Professor of Neuroscience, City University of Hong Kong

CEO & Editor in Chief, Global Bio & Investment Monthly

President, Healthcare Division, BaseBit Technologies

Chairman and CEO, Finet Group Ltd

Chairman, Food and Environmental Hygiene, Food and Health Bureau, Government Secretariat HKSAR

Founding Partner, eChinaHealth

Dean and Chair Professor, Dr. Kennedy Y.H. Wong Endowed

Chairman of AML Holdings Limited

Director General, International Iberian Nanotechnology Laboratory

Board of Directors, The BayHelix Group

Partner, SPARQ Capital

Vice President, Winner Medical Group

Board of Directors, The BayHelix Group

Principle Investigator and Academic Director at the Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences

Head and Chair Professor, Department of Ocean Science, Hong Kong University of Science and Technology

Honorary Chaiman and Hong Kong Representative, International Iberian Nanotechnology Laboratory

Choh-Ming Li Professor of Biomedical Sciences, The Chinese University of Hong Kong

Managing Director, SenseTime Hong Kong

CEO, Adicon Clinical Laboratories

Chairman of the Hong Kong Center, Macau International Healthcare Think Tank

Assistant Professor, Chemical and Biological Engineering, The Hong Kong University of Science and Technology

Deputy Inspector, Shenzhen Association for Science and Technology

Head of the North California Division, BayHelix

Director, Dr. Li Dak-Sum Research Centre

Managing Director, Good Health Capital (New York)

CEO, ShenZhen Govita Medical Laboratory

Director, Center for Chinese Medicine R & D

COO, Powder Pharmaceuticals Incorporated

President, European Federation of Biotechnology

Immediate Past President, Rotary Club Kowloon Golden Mile

Assistant Professor, Division of Life Science, The Hong Kong University of Science and Technology

Center for Advanced Measurement Science, Natiional Institute of Metrology, China

Director, Institute of Chinese Medical Sciences

CEO, AlphaSmart World Limited

Adjunct Professor, Department of Biochemistry, Chinese University of Hong Kong

Hon Professor, School of Chinese Medicine, The University of Hong Kong

Managing Partner & Attesting Officer, Philip K H Wong, Kennedy Y H Wong & Co. (Slicitors & Notaries in association with W&H Law Firm)

Director & Executive President, Guangdong Medical Valley (GDMV)

CEO, Asia Investment Fund Management Limited 

Executive Director and Medical Team Leader of Cathay Capital 

Head and Yeung Kin Man Chair Professor, Department of Biomedical Sciences, City University of Hong Kong

Partner, Marathon Venture Partners

Chief Business Officer & Executive Vice President, WuXi AppTec Co., Ltd.

Founder & CEO, Koln 3D Technology (Medical) Limited

President, MGI

Professor and Associate Head, Department of Biology, Faculty of Science, Hong Kong Baptist University

Founding Member and Former Chairman, The BayHelix Group

Partner, Deloitte Tax LLP

President, Shenzhen International Institute for Biomedical Research